Dp. Chin et al., Progress and problems in achieving the United States national target for completion of antituberculosis treatment, INT J TUBE, 4(8), 2000, pp. 744-751
Citations number
25
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
SETTING: The target for antituberculosis treatment in the United States is
for 90% of patients to complete therapy within 12 months.
OBJECTIVE: To assess progress in achieving the US national target for tuber
culosis treatment.
DESIGN: A comparison of treatment outcome in two cohorts of patients with d
rug-susceptible tuberculosis in California--those reported in 1993-1994 (84
88 patients) and 1995-1996 (7823 patients). Risk factors for delay in treat
ment completion (more than 12 months) were assessed.
RESULTS: The percentage of cases completing treatment within 12 months incr
eased in the 1995-1996 cohort (to 68.2%), primarily due to concomitant redu
ctions in delays in treatment completion (to 11.1%) and defaulting (to 2.4%
). Disparities in timely treatment completion narrowed over time and in nea
tly all subpopulations, especially in groups with lowest treatment completi
on in the 1993-1994 cohort. Remaining risk factors for delay in treatment c
ompletion included AIDS and older ages. A substantial percentage of patient
s died or moved before treatment completion.
CONCLUSIONS: Despite recent improvements, completion of antituberculosis tr
eatment in California has not reached the national target. Reaching this ta
rget will require further reductions in delays in treatment completion and
deaths during treatment, and ensuring that patients who move eventually com
plete treatment.